Nuclear Energy and Healthcare Insights

This chapter explores the resurgence of nuclear energy investments amid potential policy shifts from the Trump administration, aiming to expand the U.S. nuclear fleet. It also addresses concerns in the healthcare sector, focusing on FDA leadership and proposed regulations that could influence drug pricing and investment dynamics.